Imagine turning fish scraps and seaweed into a high-performance vitamin boost for plants. Instead of using harsh chemicals to fight pests, this project uses tiny helpful microbes wrapped in protective shells to keep crops healthy. It is like switching from industrial bleach to a natural, effective cleaner for the farm.
Organic farmers struggle to find effective, legal alternatives to copper, sulfur, and synthetic antibiotics. Current organic inputs often lack the efficacy or availability needed for large-scale farming.
Industrial-scale production processes for 2 bio-fertilizers, 1 biocontrol agent, and 1 antiparasitic treatment.
If you are a fertilizer manufacturer dealing with the high cost of raw materials — this project developed 2 fertilizers using fish discards and seaweed that provide a sustainable, circular alternative to conventional inputs.
If you are a crop protection company dealing with regulatory bans on copper and sulfur — this project developed 1 biocontrol agent and microalgal fungicides that protect crops without using contentious chemicals.
If you are a pharmaceutical company dealing with the need to reduce synthetic antibiotics in livestock — this project developed 1 antiparasitic treatment using bark extracts and immunostimulants.
Based on available project data, specific pricing is not provided, but the project explicitly aims to address product costs as a potential barrier to farmer acceptance.
Yes, the project aims for the industrial production of at least 1 biocontrol agent, 2 fertilizers, and 1 antiparasitic treatment.
Based on available project data, specific licensing terms are not mentioned, though the consortium includes 6 industry partners and 6 SMEs likely involved in commercialization.
The project focuses on replacing contentious inputs like copper- and sulfur-based fungicides and synthetic antibiotics to meet organic farming standards and regulatory challenges.
The project runs from 2025-05-01 to 2029-04-30, with scale-up and testing occurring from the early stages.
The consortium is well-balanced for commercialization, featuring 20 partners across 8 countries. With a 30% industry ratio (6 companies, including 6 SMEs), there is a strong link between the 11 research/university entities and the market, ensuring that the developed bio-solutions are viable for industrial scale-up.
Contact the Consiglio Nazionale delle Ricerche (CNR) in Italy.
Contact SciTransfer to connect with the BIO2 consortium for licensing opportunities.
